Cargando…

Use of statins in community-acquired pneumonia in intensive care settings: is there a survival advantage?

Detalles Bibliográficos
Autores principales:	Khanna, A, Gibbs, R, Webster, S, Al-shather, H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066941/ http://dx.doi.org/10.1186/cc9687

Ejemplares similares

Aetiology of pneumonia in the ICU: the need for early Gram-negative cover
por: Khanna, A, et al.
Publicado: (2011)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Association of prior statin therapy with cytokine profiles and outcomes in patients hospitalized with community acquired pneumonia
por: Milbrandt, E, et al.
Publicado: (2005)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Epidemiology of community-acquired bacteremia patients admitted to the intensive care unit
por: Castro, Guiomar, et al.
Publicado: (2007)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-acquired pneumonia (CAP) in the intensive care unit
por: Leroy, O, et al.
Publicado: (2004)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Compliance of a ventilator-associated pneumonia care bundle in an adult intensive care setting
por: Wigmore, G, et al.
Publicado: (2014)

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

Statin therapy on admission to intensive care and outcome: an observational cohort study
por: Mackay, A, et al.
Publicado: (2010)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

A new severity score for community-acquired pneumonia: PARB score
por: Uchiyama, N, et al.
Publicado: (2010)

Criteria of the systemic inflammatory response syndrome in patients with community-acquired pneumonia
por: Ustyantseva, I, et al.
Publicado: (2006)

Coagulation in hospitalized community-acquired pneumonia: disturbances in even the least ill
por: Reade, MC, et al.
Publicado: (2008)

Association of C-Reactive Protein and Outcome in Patients With Community-Acquired Pneumonia
por: Park, JK, et al.
Publicado: (2015)

Community-acquired bacteraemia with sepsis in adults admitted to the intensive care unit: a prospective multicentre study
por: Cardoso, Teresa, et al.
Publicado: (2007)

Implementing national guidelines in intensive care patients with ventilator-associated, hospital-acquired, and healthcare-associated pneumonia: the IMPACT-HAP project
por: Kett, DH, et al.
Publicado: (2008)

Pre-analytic factors and initial biomarker levels in community- acquired pneumonia patients
por: Kutz, A, et al.
Publicado: (2014)

Analysis of the mortality rate in patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Severe pneumonia in critically ill cancer patients: clinical outcomes and a comparison between healthcare-associated pneumonia and community-acquired pneumonia
por: Rabello, Ligia SCF, et al.
Publicado: (2013)

Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia
por: Suberviola, B, et al.
Publicado: (2011)

Beneficial effects of antiplatelet drugs in patients with community-acquired pneumonia and in endotoxin shock in mice
por: Winning, J, et al.
Publicado: (2007)

Effects of systemic steroid in patients with severe community-acquired pneumonia requiring mechanical ventilation
por: Chon, G, et al.
Publicado: (2009)

Defining severe community-acquired pneumonia: a significant barrier to improving patient outcomes
por: Balp, MM, et al.
Publicado: (2009)

Assessment of specific risk scores for patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Aetiology of community-acquired pneumonia in the ICU setting and its effect on mortality, length of mechanical ventilation and length of ICU stay: a 1-year retrospective review
por: Ryan, D, et al.
Publicado: (2014)

Implementation of a ventilator care bundle to reduce the incidence of ventilator acquired pneumonia
por: Mandal, AK, et al.
Publicado: (2011)

Simple and fast prediction of Legionella sp. in community-acquired pneumonia: validation of a prediction rule
por: Haubitz, S, et al.
Publicado: (2013)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Glycemic variability as a risk factor of intensive care unit-acquired weakness
por: Mörgeli, R, et al.
Publicado: (2015)

Age-related differences of outcomes in patients hospitalized with community-acquired pneumonia are not explained by differences in immune response
por: Kale, S, et al.
Publicado: (2010)

Community-acquired pneumonia: a comparison of clinical treatment failure in patients treated with either penicillin or cefuroxime
por: Ekloef, Josefin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5vetro2opjndjlbkf14aenrlvr